SEC Form 4 · accession 0001209191-17-014587
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey N West
Officer — SVP & Controller
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 11:02 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Feb 23, 2017 | X | 13,212 | $43.40 | A | 24,587 | D | |
| Ordinary Common Stock, $0.01 par value | Feb 24, 2017 | X | 300 | $43.40 | A | 24,887 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Feb 23, 2017 | S | 12,912 | $80.2754 | D | 11,975 | D | |
| Ordinary Common Stock, $0.01 par valueF3 | Feb 23, 2017 | S | 300 | $81.1167 | D | 11,675 | D | |
| Ordinary Common Stock, $0.01 par valueF4 | Feb 24, 2017 | S | 100 | $80.00 | D | 11,575 | D | |
| Ordinary Common Stock, $0.01 par valueF5 | Feb 24, 2017 | S | 100 | $81.05 | D | 11,475 | D | |
| Ordinary Common Stock, $0.01 par valueF6 | Feb 24, 2017 | S | 100 | $82.10 | D | 11,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy(F8,F7 | $43.40 | Feb 23, 2017 | X | 13,212 | D | — | Feb 1, 2018 | Common Stock | 13,212 | 3,454 | D |
| Stock Option (right to buy)F8,F7 | $43.40 | Feb 24, 2017 | X | 300 | D | — | Feb 1, 2018 | Common Stock | 300 | 3,154 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $80.00 to $80.90, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $81.05 to $81.20, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F4The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $80.00. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F5The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $81.05. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F6The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $82.10. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F7All of the stock options in this tranche have vested in full.
- F8Not applicable.